mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |